In recent years, the incorporation of ESG into the business cycle and operational decisions of life sciences companies in the EU has become a critical aspect of financial and organizational performance measures.
Michele Tagliaferri explains how ESG regulations that will soon be enacted in Europe under the EU Green Deal will turn ESG programs from a “nice to have” to a “must have.”
Trendspotting 2023: On the Pulse of Global Life Sciences
EU’s Green Deal Turns ESG Programs Into a “Must Have”
January 2023
Summary
Authors:
Michele Tagliaferri
Contacts
Stay Up To Date